Rationale for controlled Oxygen Therapy |
Excess oxygen can be harmful. Like many drugs, oxygen can be
associated with toxicity and excess oxygen can be harmful to the
lungs (pulmonary endothelium). The use of inspired oxygen greater
than 60% should be avoided if possible. Decreasing the amount of
supplemented oxygen at the earliest possible time should be routine
practice.
1. Irrespective of the
cause, hypoxia should be treated using a Ventimask which gives an
appropriate dosage, to bring oxygen tension and saturation to near
normal.
2. When acute ventilatory
failure exists, indicated by CO2 retention, then O2 therapy is only
indicated, if there is a concomitant hypoxia. Examples would be:
CNS depression, Guillian-Barre syndrome and flail chest, all of
which require treatment by IPPV if severe.
3. When chronic
ventilatory failure and CO2 retention occur such as in chronic
bronchitis and emphysema, patients rely on hypoxia to drive
respiration. Excess Oxygen dosage in such patients will thus cause
respiratory depression and narcosis. However, they will benefit
from a small increase in inspired Oxygen. 24% and 28% Ventimasks
are appropriate under these circumstances and will produce dramatic
improvement in saturation and levels of consciousness.
4. Where there is excess
shunting of venous blood without CO2 retention, as in infective
pneumonia, direct lung trauma or contusion, shock lung, acid
aspiration syndrome or chronic congestive cardiac failure, higher
oxygen concentrations (35%-60%) are often required and can be
administered safely. Monitoring of arterial oxygen while Ventimasks
are in use will indicate whether the lungs are improving or
deteriorating. When parenchymal lung failure is so severe that 60%
inspired oxygen is not sufficient to achieve satisfactory blood
oxygen levels, IPPV is indicated even if alveolar ventilation
assessed by CO2 measurement is adequate. In the flow chart below,
selection of the appropriate Ventimask is related to the various
types of respiratory disorder.
